Search results for "Multiple sclerosis"

Sanofi and its subsidiary Genzyme have announced results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug Alemtuzumab ( Lemtrada ) to the approve ... read article

Focus